Baseline Gustave Roussy Immune Score and Survival in Extensive-Stage Small-Cell Lung Cancer Treated with First-Line Chemoimmunotherapy
Baseline Gustave Roussy Immune Score (GRIm) was the most consistent candidate prognostic marker in this real-world ES-SCLC cohort and was identified markedly shorter overall and progression-free survival.
David Sánchez-García, Miguel Borregón-Rivilla, Alejandro Moya-Martínez et al.
· Cancer Management and Resear... · 0 citations